Target intelligence / Profile preview

Melanoregulin pseudogene 1 (MREGP1)

Target
MREGP1
01

Overview

Melanoregulin pseudogene 1 (MREGP1) is classified as a pseudogene, meaning it is a genomic sequence resembling the functional melanoregulin (MREG) gene but is generally considered nonfunctional and does not encode a protein[1][4]. There is currently no evidence supporting a biological or therapeutic role for MREGP1. Most available scientific studies, including those describing the molecular structure, organelle transport, or disease implications, refer to the related functional gene melanoregulin (MREG) and not to MREGP1 or other pseudogenes[2][3]. If more information about MREGP1 becomes available, molecular classification and disease role data should be updated accordingly. Clarification: - The identifier "MREGP1" is correct for the locus, but it is not a therapeutic target and is only a pseudogene—entries referencing molecular function, drug interactions, or disease association concern the protein-coding gene MREG, not MREGP1[1][4]. - If you intended to inquire about the functional protein "melanoregulin," a distinct entry referring to MREG (the parent protein-coding gene) should be created. Melanoregulin is a vesicular transport protein and is involved in organelle biogenesis and specific pigment cell disorders[2][3]. Summary of findings: - MREGP1 is a pseudogene and not a therapeutic target. - No molecular function, disease role, or drug interactions are known for MREGP1. - Most structured scientific data relate to melanoregulin (MREG), not MREGP1. If you require structured data for the parent gene "melanoregulin (MREG)" as a protein-coding target, that information should be gathered separately.

Other names
MREGP1

Beyond the preview

Go deeper on Melanoregulin pseudogene 1 (MREGP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoregulin pseudogene 1 (MREGP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call